Advertisement
Screener

OptimizeRx Corporation (OPRX) Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities

OptimizeRx Corporation Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities

OptimizeRx Corporation (OPRX) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$6.19 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-13

  • OptimizeRx Corporation increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $1.80M, a 45.22% decline year-over-year.
  • OptimizeRx Corporation increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$7.99M, a 1035.48% decline year-over-year.
  • OptimizeRx Corporation increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $1.46M, a 52.10% decline year-over-year.
  • OptimizeRx Corporation increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was -$2.23M, a 933.33% decline year-over-year.
  • OptimizeRx Corporation increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $3.37M, a 220.42% increase from fiscal 2024.
  • OptimizeRx Corporation increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $1.05M, a 19.19% decline from fiscal 2023.
  • OptimizeRx Corporation increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $1.30M.
Period endIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month
2026-06-30$1.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$6.19M
10-Q · filed 2026-08-13
-$4.73M
derived: sum of 3 quarters · filed 2026-08-13
-$6.95M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$7.99M
10-Q · filed 2026-05-13
-$6.53M
derived: sum of 2 quarters · filed 2026-05-13
-$8.75M
derived: sum of 3 quarters · filed 2026-05-13
-$5.47M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$1.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
-$764.00K
derived: sum of 2 quarters · filed 2026-03-12
$2.52M
derived: sum of 3 quarters · filed 2026-08-13
$3.37M
10-K · filed 2026-03-12
2025-09-30-$2.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$1.06M
derived: sum of 2 quarters · filed 2026-08-13
$1.91M
10-Q · filed 2025-11-07
$4.96M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$3.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$4.14M
10-Q · filed 2026-08-13
$7.19M
derived: sum of 3 quarters · filed 2026-08-13
$7.46M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$854.00K
10-Q · filed 2026-05-13
$3.90M
derived: sum of 2 quarters · filed 2026-05-13
$4.17M
derived: sum of 3 quarters · filed 2026-05-13
$2.27M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$3.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$3.32M
derived: sum of 2 quarters · filed 2026-03-12
$1.42M
derived: sum of 3 quarters · filed 2026-03-12
$1.05M
10-K · filed 2026-03-12
2024-09-30$267.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$1.64M
derived: sum of 2 quarters · filed 2025-11-07
-$2.00M
10-Q · filed 2025-11-07
-$1.20M
derived: sum of 4 quarters · filed 2025-11-07
2024-06-30-$1.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
-$2.26M
10-Q · filed 2025-08-08
-$1.47M
derived: sum of 3 quarters · filed 2025-08-08
2024-03-31-$362.00K
10-Q · filed 2025-05-13
$432.00K
derived: sum of 2 quarters · filed 2025-05-13
2023-12-31$794.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20
$1.30M
10-K · filed 2025-03-20
2023-09-30$509.00K
10-Q · filed 2024-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
TEN Holdings, Inc. (XHLD)United States$0.152B
Future FinTech Group Inc. (FTFT)$0.144B
Datavault AI Inc. (DVLT)United States$0.144B-1.77
RESOURCES CONNECTION, INC. (RGP)United States$0.129B-3.84
DHI GROUP, INC. (DHX)United States$0.205B132.15
COMSCORE, INC. (SCOR)United States$0.073B-6.35
Research Solutions, Inc. (RSSS)United States$0.071B27.67
Getty Images Holdings, Inc. (GETY)United States$0.068B-2.33
FiscalNote Holdings, Inc. (NOTE)United States$0.065B
Bridger Aerospace Group Holdings, Inc. (BAER)United States$0.049B-9.14